# Role of Dyadic Proteins in Proper Heart Function and Disease

**Authors:** Carter Liou, Michael T. Chin

PMC · DOI: 10.3390/ijms26157478 · International Journal of Molecular Sciences · 2025-08-02

## TL;DR

This paper explains how dyadic proteins are crucial for heart function and how their dysfunction leads to heart diseases like cardiomyopathies and arrhythmias.

## Contribution

The paper highlights the role of specific dyadic proteins and gene therapy in treating dyadic dysfunction.

## Key findings

- Dyadic proteins like CMYA5, JPH2, and BIN1 maintain the dyadic cleft essential for heart function.
- Loss-of-function mutations in dyadic proteins cause cardiomyopathies and arrhythmias.
- AAV gene therapy can rescue dyadic dysfunction and improve heart conditions.

## Abstract

Cardiovascular disease encompasses a wide group of conditions that affect the heart and blood vessels. Of these diseases, cardiomyopathies and arrhythmias specifically have been well-studied in their relationship to cardiac dyads, nanoscopic structures that connect electrical signals to muscle contraction. The proper development and positioning of dyads is essential in excitation–contraction (EC) coupling and, thus, beating of the heart. Three proteins, namely CMYA5, JPH2, and BIN1, are responsible for maintaining the dyadic cleft between the T-tubule and junctional sarcoplasmic reticulum (jSR). Various other dyadic proteins play integral roles in the primary function of the dyad—translating a propagating action potential (AP) into a myocardial contraction. Ca2+, a secondary messenger in this process, acts as an allosteric activator of the sarcomere, and its cytoplasmic concentration is regulated by the dyad. Loss-of-function mutations have been shown to result in cardiomyopathies and arrhythmias. Adeno-associated virus (AAV) gene therapy with dyad components can rescue dyadic dysfunction, which results in cardiomyopathies and arrhythmias. Overall, the dyad and its components serve as essential mediators of calcium homeostasis and excitation–contraction coupling in the mammalian heart and, when dysfunctional, result in significant cardiac dysfunction, arrhythmias, morbidity, and mortality.

## Linked entities

- **Genes:** CMYA5 (cardiomyopathy associated 5) [NCBI Gene 202333], JPH2 (junctophilin 2) [NCBI Gene 57158], BIN1 (bridging integrator 1) [NCBI Gene 274]
- **Proteins:** CMYA5 (cardiomyopathy associated 5), JPH2 (junctophilin 2), BIN1 (bridging integrator 1)
- **Chemicals:** Ca2+ (PubChem CID 271)
- **Diseases:** cardiomyopathies (MONDO:0004994)

## Full-text entities

- **Genes:** BIN1 (bridging integrator 1) [NCBI Gene 274] {aka AMPH2, AMPHL, CNM2, SH3P9}, JPH2 (junctophilin 2) [NCBI Gene 57158] {aka CMD2E, CMH17, JP-2, JP2}, CMYA5 (cardiomyopathy associated 5) [NCBI Gene 202333] {aka C5orf10, SPRYD2, TRIM76}
- **Diseases:** Cardiovascular disease (MESH:D002318), arrhythmias (MESH:D001145), muscle (MESH:D019042), cardiac dysfunction (MESH:D006331), myocardial contraction (MESH:C536214), cardiomyopathies (MESH:D009202)
- **Chemicals:** calcium (MESH:D002118), Ca2+ (-)
- **Species:** Adeno-associated virus (species) [taxon 272636]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12347279/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12347279/full.md

## References

57 references — full list in the complete paper: https://tomesphere.com/paper/PMC12347279/full.md

---
Source: https://tomesphere.com/paper/PMC12347279